October 2001
Medical Device & Diagnostic Industry
Selected Contents
EDITOR'S
PAGE:
REMEMBERING THOMAS BURNETT JR.
COVER STORY:
Is
ISO 9001 Obsolete?
Edward R. Kimmelman
With the publication of the 2000 revision of the general ISO quality systems
standard, the medical device industry has concluded that it must follow a separate
course. A pending update to the industry's own ISO standard, 13485, will formalize
the split.
Using
Measurement to Improve Quality
Daniel P. Olivier and Paschal Dwane
The new ISO 9001:2000 standard puts an unprecedented emphasis on measurement.
Although companies may find compliance challenging, they will benefit from improved
quality systems.
Reliability
Technology for Manufacturers: Engineering Better Devices
B.S. Dhillon
The medical device industry is among the wide cross section of industries that
benefit from reliability engineering. Four methods presented here offer manufacturers
concrete techniques to improve the effectiveness of their medical devices.
Outsourcing:
Striking the Proper Balance
William Leventon
While outsourcing design and manufacturing processes, OEMs should stay involved
and maintain in-house expertise.
Using Computer-Aided Design
to Enhance Product Development
Gregg Nighswonger
More than a design tool, CAD can improve communication, help control the design
process, and reduce time to market.
Sidebar: Developing A Fingertip-Sized Implantable Heart Pump
Answering
the Call for Harmonization of Medical Device Alarms
Michael E. Wiklund and Eric A. Smith
Industry sounds off on a new document aimed at standardizing the design of alarm
systems for use in medical equipment.
R&D DIGEST:
A monthly review of new technologies
and medical device innovations
THIS MONTH: Microjaws to Deliver Drugs at Cellular Level * Creating Imprinted
Gels for Insulin Biosensors * Clay Reduces Permeability of Implantable Polymer
Components * Body Simulator Preserves Kidney for Transplant * Nanosensor Detects
DNA Without Amplification
Sidebar:
President's 2002 Budget Request
Continues Commitment to NIH
WASHINGTON
WRAP-UP:
Bush
Taming FDA? Some Think Not
James G. Dickinson
The appointment of a conservative chief counsel at FDA has industry wondering if it is the first in a series of moves designed to establish an attitude of less-rigorous enforcement at the agency.
FIRST PERSON:
Looking
Toward A New Medical Technology Policy
The emergence of new medical technologies requires FDA reform, liability relief, and a reassessment of current policies on third-party reimbursement.
Curing system developed.
Press slide granulators designed for extrusion and blow molding.
Corporation announces expansion, new focus, and more!







